arginine and novobiocin

arginine has been researched along with novobiocin in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-199011 (44.00)18.7374
1990's10 (40.00)18.2507
2000's1 (4.00)29.6817
2010's3 (12.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Bresnahan, D; Chalkley, R; Cotten, M; Sealy, L; Thompson, S1
Neuhard, J1
Nishikori, Y; Shimoyama, M; Tsuchiya, M; Yamada, K1
YUDKIN, MD1
Carvalho, DC; Garrido, SS; Marchetto, R; Scatigno, AC; Trovatti, E1
Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K1
DeMarini, DM; Lawrence, BK1
Lorico, A; Rappa, G; Sartorelli, AC2
Adachi, K; Andrea, JE; Morgan, AR1
Schedl, P; Udvardy, A1
Chung, TD; Drake, FH; Hofmann, GA; Johnson, RK; Mattern, MR; Mirabelli, CK; Woessner, RD1
Elkind, MM; Shibuya, ML; Utsumi, H1
Baloch, Z; Coffman, FD; Cohen, S1
Desrosiers, R; Tanguay, RM1
Boyce, RA; Hertzberg, RP; Mattern, MR; Schein, PS; Tan, KB1
Legerski, RJ; Penkala, JE; Peterson, CA; Wright, DA1
Beerman, TA; Sigmund, RD; Woynarowski, JM1
Liu, LF; Rowe, TC; Yang, L1
Gottesfeld, JM1
Mui, SC; Strauss, PR; Todt, JC; Zhang, LH1
Lönn, S; Lönn, U1

Other Studies

25 other study(ies) available for arginine and novobiocin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase.
    Nucleic acids research, 1986, May-12, Volume: 14, Issue:9

    Topics: Animals; Arginine; Cells, Cultured; Chemical Precipitation; Chromosomal Proteins, Non-Histone; Histones; In Vitro Techniques; Isoelectric Point; Liver Neoplasms, Experimental; Novobiocin; Osmolar Concentration; Protein Binding; Rats; Structure-Activity Relationship

1986
Studies on the acid-soluble nucleotide pool in thymine-requiring mutants of Escherichia coli during thymine starvation. 3. On the regulation of the deoxyadenosine triphosphate and deoxycytidine triphosphate pools of Escherichia coli.
    Biochimica et biophysica acta, 1966, Oct-24, Volume: 129, Issue:1

    Topics: Adenosine Triphosphate; Arginine; Carbon Isotopes; Chromatography; Cytosine Nucleotides; Deoxyuridine; DNA, Bacterial; Escherichia coli; Floxuridine; Histidine; Methionine; Novobiocin; Nucleotides; Phosphorus Isotopes; Thymine; Uracil Nucleotides

1966
Automodification of arginine-specific ADP-ribosyltransferase purified from chicken peripheral heterophils and alteration of the transferase activity.
    Archives of biochemistry and biophysics, 1994, Volume: 308, Issue:1

    Topics: Adenosine Diphosphate Ribose; Animals; Arginine; Chickens; Electrophoresis, Polyacrylamide Gel; Hydroxylamine; Hydroxylamines; Isoenzymes; Kinetics; Leukocytes; Molecular Weight; NAD; Novobiocin; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Substrate Specificity

1994
THE EFFECT OF PENICILLIN, NOVOBIOCIN, STREPTOMYCIN AND VANCOMYCIN ON MEMBRANE SYNTHESIS BY PROTOPLASTS OF BACILLUS MEGATERIUM.
    The Biochemical journal, 1963, Volume: 89

    Topics: Antimetabolites; Arginine; Bacillus megaterium; Carbon Isotopes; Glycerol; Histidine; Muramidase; Novobiocin; Penicillin G; Penicillins; Proteins; Protoplasts; Research; Streptomycin; Tyrosine; Vancomycin

1963
Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
    The journal of peptide research : official journal of the American Peptide Society, 2005, Volume: 65, Issue:5

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Arginine; Binding Sites; Binding, Competitive; Chromatography, Affinity; Coumarins; DNA Gyrase; Drug Design; Escherichia coli Proteins; Magnesium; Molecular Sequence Data; Novobiocin; Peptide Fragments

2005
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells.
    Experimental cell research, 1992, Volume: 203, Issue:1

    Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1992
Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks.
    Mutation research, 1992, Volume: 267, Issue:1

    Topics: Amsacrine; Azides; Bacteriophage lambda; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Ellipticines; Escherichia coli; Free Radicals; Hydrogen Peroxide; Lysogeny; Nalidixic Acid; Novobiocin; Oxolinic Acid; Oxygen; Paraquat; Sodium Azide; SOS Response, Genetics; Teniposide; Topoisomerase II Inhibitors; Virus Replication

1992
Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26).
    International journal of cancer, 1992, Jul-09, Volume: 51, Issue:5

    Topics: Adenocarcinoma; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; DNA; DNA Topoisomerases, Type II; Drug Synergism; Etoposide; Humans; Leukemia; Lung Neoplasms; Novobiocin; RNA; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1992
Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Molecular pharmacology, 1991, Volume: 40, Issue:4

    Topics: Amsacrine; Animals; Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Circular; DNA, Single-Stranded; DNA, Superhelical; Ethidium; Fluorescence; Fluorometry; Hydrogen-Ion Concentration; Kinetics; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

1991
Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.
    Molecular and cellular biology, 1991, Volume: 11, Issue:10

    Topics: Animals; Binding Sites; Cells, Cultured; Chromatin; DNA; DNA Topoisomerases, Type II; DNA, Ribosomal; Drosophila; Histones; Novobiocin; Nucleic Acid Conformation; Nucleosomes; RNA, Transfer; Teniposide

1991
Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.
    Cancer research, 1990, May-15, Volume: 50, Issue:10

    Topics: Animals; Blotting, Northern; Blotting, Western; Cell Division; Cell Line; Cell Nucleus; Cell Transformation, Neoplastic; DNA Damage; DNA Topoisomerases, Type II; Genes, ras; Mice; Molecular Weight; Novobiocin; RNA, Messenger; Teniposide; Thiobarbiturates; Topoisomerase II Inhibitors

1990
Novobiocin inhibits the repair of potentially lethal damage but not the repair of sublethal damage.
    Radiation research, 1990, Volume: 123, Issue:1

    Topics: Amsacrine; Animals; Cell Line; Cricetinae; DNA Damage; DNA Repair; Etoposide; Novobiocin; Teniposide; Topoisomerase II Inhibitors

1990
Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II.
    Cancer research, 1990, Oct-15, Volume: 50, Issue:20

    Topics: Aclarubicin; Animals; Cell Cycle; Cell Differentiation; Doxorubicin; Leukemia, Myelomonocytic, Chronic; Mice; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tretinoin; Tumor Cells, Cultured

1990
Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
    Journal of immunology (Baltimore, Md. : 1950), 1990, Nov-01, Volume: 145, Issue:9

    Topics: Aminocoumarins; Camptothecin; Cell Line; Cell Survival; Coumarins; Drug Synergism; In Vitro Techniques; L Cells; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Necrosis Factor-alpha

1990
Transcriptional inhibitors affecting topoisomerase II induce changes in histone methylation patterns similar to those induced by heat shock.
    Biochemical and biophysical research communications, 1989, Aug-15, Volume: 162, Issue:3

    Topics: Animals; Camptothecin; Cells, Cultured; Dactinomycin; Drosophila melanogaster; Ethidium; Histones; Hot Temperature; In Vitro Techniques; Methylation; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Uridine

1989
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.
    NCI monographs : a publication of the National Cancer Institute, 1987, Issue:4

    Topics: Amsacrine; Burkitt Lymphoma; Cell Line; Cell Survival; Chromatin; DNA Topoisomerases, Type II; Drug Resistance; Humans; Kinetics; Mechlorethamine; Novobiocin; Podophyllotoxin; Teniposide; Tumor Stem Cell Assay

1987
Repair of UV-induced lesions in Xenopus laevis oocytes.
    Molecular and cellular biology, 1987, Volume: 7, Issue:12

    Topics: Animals; Camptothecin; Deoxycytosine Nucleotides; DNA; DNA Repair; DNA, Circular; DNA, Superhelical; Female; Kinetics; Microinjections; Novobiocin; Oocytes; Plasmids; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription, Genetic; Ultraviolet Rays; Xenopus laevis

1987
Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
    Biochimica et biophysica acta, 1988, May-06, Volume: 950, Issue:1

    Topics: Adenosine Triphosphate; Amsacrine; Animals; Cross-Linking Reagents; DNA; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Novobiocin; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors

1988
Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
    Cancer research, 1985, Volume: 45, Issue:11 Pt 2

    Topics: Animals; Cells, Cultured; Chemical Precipitation; DNA Topoisomerases, Type II; DNA, Viral; Etoposide; Haplorhini; Novobiocin; Podophyllotoxin; Simian virus 40; Teniposide

1985
Novobiocin inhibits RNA polymerase III transcription in vitro by a mechanism distinct from DNA topoisomerase II.
    Nucleic acids research, 1986, Mar-11, Volume: 14, Issue:5

    Topics: Aminocoumarins; Camptothecin; Coumarins; DNA-Directed RNA Polymerases; HeLa Cells; Novobiocin; RNA Polymerase III; RNA, Ribosomal; RNA, Transfer; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic

1986
Role for topoisomerases in the release of DNA into the detergent-soluble fraction of eukaryotic cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1986, Volume: 83, Issue:16

    Topics: Aminoacridines; Amsacrine; Animals; Camptothecin; Detergents; DNA; DNA Topoisomerases, Type I; Intercalating Agents; Kinetics; Mice; Novobiocin; Solubility; Spleen; Teniposide; Thymidine

1986
5,6-Dichloro-1-beta-O-ribofuranosylbenzimidazole induces DNA damage by interfering with DNA topoisomerase II.
    European journal of biochemistry, 1987, May-04, Volume: 164, Issue:3

    Topics: Aphidicolin; Cells, Cultured; Chemical Precipitation; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA; Electrophoresis, Agar Gel; Etoposide; Humans; Novobiocin; Proteins; Ribonucleosides; Teniposide; Topoisomerase II Inhibitors

1987